Bausch & Lomb Corp BLCO

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $17.03
Market Cap $6.06B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-20.0% YoY
$12.00M
3-Yr CAGR: 26.0%
Net Income ↑33.3% YoY
-$8.00M
Net Margin: -66.7%
Free Cash Flow ↑31.8% YoY
$232.00M
FCF Yield: 3.83%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-0.1%
ROA: -0.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BLCO)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2023: Revenue YoY (+150.0%) is identical to Gross Profit YoY (+150.0%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
  • FY 2024: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
  • FY 2024: Revenue YoY (+0.0%) is identical to Net Income YoY (+0.0%). Verify the underlying Revenue and Net Income values for FY 2024 and FY 2023.
  • FY 2025: Revenue YoY (-20.0%) is identical to Gross Profit YoY (-20.0%). Verify the underlying Revenue and Gross Profit values for FY 2025 and FY 2024.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $3.0M $3.0M $-1.0M $522.0M $269.0M
FY 2021 $1,796.0M +59,766.7% $329.0M $-11.0M -1,000.0% $873.0M $842.0M +213.0%
FY 2022 $6.0M -99.7% $6.0M $-9.0M +18.2% $345.0M $307.0M -63.5%
FY 2023 $15.0M +150.0% $15.0M $-12.0M -33.3% $-17.0M $-82.0M -126.7%
FY 2024 $15.0M 0.0% $15.0M $-12.0M 0.0% $232.0M $176.0M +314.6%
FY 2025 $12.0M -20.0% $12.0M $-8.0M +33.3% $283.0M $232.0M +31.8%
$

Valuation

Market Price $17.03
Market Cap $6.06B
Enterprise Value $10.72B
P/E Ratio N/A
P/B Ratio 0.94
FCF Yield 3.83%
Dividend Yield N/A
Shares Outstanding 356,536,400
%

Profitability & Margins

Gross Margin 0.58%
Operating Margin 941.67%
Net Margin -66.67%
Return on Equity (ROE) -0.12%
Return on Assets (ROA) -0.06%
Asset Turnover 0.00x
Revenue 3-Yr CAGR 25.99%
🛡️

Financial Health & Liquidity

Current Ratio 0.26
Cash Ratio 0.26
Debt / Equity 0.782
Debt / Assets 0.360
Cash & Equivalents $383.00M
Total Debt $5.04B
Book Value / Share $18.09
💧

Cash Flow Efficiency

Operating Cash Flow $283.00M
Capital Expenditures (CapEx) $51.00M
Free Cash Flow $232.00M
OCF / Revenue 2,358.33%
FCF / Revenue 1,933.33%
FCF 3-Yr CAGR -8.91%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $18.09
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $14.02B
Total Liabilities $7.50B
Stockholders' Equity $6.45B
Current Assets $383.00M
Current Liabilities $1.49B